17:20 EST Coya Therapeutics (COYA) files to sell 1.38M shares of common stock for holders Don't Miss our Black Friday Offers: Discover the latest stocks recommended by top Wall Street analysts ...

An investigator has posted data on Coya Therapeutics’ COYA 301, linking the IL-2 asset to improvements in biomarkers and cognition on secondary and exploratory endpoints in a small Alzheimer’s ...

Majority of investors in offering are existing institutional stockholders of Coya The gross proceeds to the Company from the private placement are expected to be approximately $10.0 million ...

Coya Therapeutics (COYA) announced that it has entered into definitive securities purchase agreements for the purchase and sale of an aggregate of 1.379M shares of its common stock in a private ...

Coya Therapeutics (NASDAQ:COYA) shares tumbled 23% Tuesday after the company reported mixed results from a Phase 2 clinical trial of its therapy candidate LD IL-2 in the treatment of Alzheimer’s ...